Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Solstice Oncology, Inc.

Clinical trials sponsored by Solstice Oncology, Inc., explained in plain language.

Not yet recruiting 1

Can a Two-Drug immunotherapy combo shrink MSS colon cancer before surgery?

Disease control Not yet recruiting

This phase 2 trial tests whether giving two immunotherapy drugs, pembrolizumab and porustobart, before surgery can shrink tumors in adults with a common type of colon cancer called MSS (microsatellite stable) that has not spread. Participants receive the drugs through a vein, wit…

Phase 2 • Sponsor: Solstice Oncology, Inc. • Aim: Disease control

Last updated Sep 10, 2026 00:00 UTC